Experience

Thirty Madison to Be Acquired by Remedy Meds

September 3, 2025

Cooley advised Thirty Madison, a specialty healthcare company offering high-quality virtual specialized care for patients experiencing a range of conditions, on its definitive agreement to be acquired by Remedy Meds in an all-stock transaction valued in excess of $500 million.

Read more

Related contacts

Izzy Lubarsky
Partner, New York
Adam Dinow
Partner, New York
Bill Roegge
Partner, New York
Jenny Ge
Associate, Santa Monica
Edward (Teddy) Nimetz
Associate, New York
Scott D. Rudin
Associate, New York
Kevin Cooper
Partner, New York
Len Jacoby
Partner, New York
Adam J. Longenbach
Partner, New York
Eileen Marshall
Partner, Washington, DC
Kristen Mathews
Partner, New York
Jeremy Morrison
Partner, Washington, DC
Nyron J. Persaud
Partner, New York
Michael Tollini
Partner, Washington, DC
Sharon Connaughton
Special Counsel, Washington, DC
Tamara Chin Loy
Associate, Washington, DC
Sharon Davidov
Associate, New York
Mari Dugas
Associate, Washington, DC
Michael Gladstone
Associate, New York
Tony P. Guan
Associate, Santa Monica
Allison Kutner
Associate, New York
Jon Margareten
Associate, New York
Madeleine Mavro
Associate, New York
Shante Mays
Associate, Reston

Related Practices & Industries

Eagle Pharmaceuticals’ Cooperation Agreement With Nantahala Capital Management

August 28, 2025

Cooley advised Eagle Pharmaceuticals, a fully integrated pharmaceutical company with research and development, clinical, manufacturing and commercial expertise, on its cooperation agreement with Nantahala Capital Management, a holder of approximately 38% of Eagle’s outstanding shares.

Read more

Related contacts

Bill Roegge
Partner, New York
Sarah Sellers
Partner, New York
Marc Recht
Partner, Boston
Pat O'Connell
Associate, New York
Asa Henin
Partner, San Diego
Paul Alexander
Associate, Washington, DC
Nathan Baum
Special Counsel, New York
Luke Cadigan
Partner in Charge – Boston, Boston
Tijana Brien
Partner, Palo Alto
Ariane A. Andrade
Partner, Chicago

Related Practices & Industries

Y-mAbs Therapeutics Agrees to Acquisition by SERB Pharmaceuticals

August 5, 2025

Cooley advised Y-mAbs Therapeutics, a commercial-stage biopharmaceutical company focused on the development and commercialization of antibody-based therapeutics for the treatment of cancer, on its definitive merger agreement with SERB Pharmaceuticals. Under the agreement, SERB will acquire Y-mAbs, including its lead commercial oncology asset, DANYELZA, in an all-cash transaction representing an equity value of approximately $412 million.

Read more

Related contacts

Bill Sorabella
Partner, New York
Bill Roegge
Partner, New York
Div Gupta
Partner, New York
Sarah Sellers
Partner, New York
Christophe Beauduin
Partner, New York
Megan Browdie
Partner, Washington, DC
Brad Goldberg
Partner, New York
Christopher Kimball
Partner, Washington, DC
Eileen Marshall
Partner, Washington, DC
Darah Protas
Partner, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Julia Kim
Special Counsel, New York
Justin Kisner
Special Counsel, San Diego
MaryBeth Shreiner
Special Counsel, Reston
Karen Tsai
Special Counsel, Washington, DC
Amanda Weiss
Special Counsel, New York
Rajdeep Roger Bains
Associate, San Diego
Dayne Brown
Associate, New York
Norma Chayo Dichi
Associate, Washington, DC
Sharon Davidov
Associate, New York
Athina Gaki
Associate, Brussels
Kyle Hess
Associate, New York
Katie Kaufman
Associate, Boston
Nicollette R. Kirby
Associate, Washington, DC
Christopher Nickas
Associate, New York
Arda Can Tekin
Associate, London
Shaun (Tianjie) Wang
Associate, New York

Related Practices & Industries

Movable Ink to Be Acquired by STG

June 26, 2025

Cooley advised Movable Ink, an artificial intelligence-powered personalized content platform, on its definitive agreement to be acquired by STG. The transaction is expected to close in July 2025.

Read more

Related contacts

Adam Dinow
Partner, New York
Bill Sorabella
Partner, New York
Bill Roegge
Partner, New York
Nathan Baum
Special Counsel, New York
Robert Warshaw
Associate, New York
Kyle Hess
Associate, New York
Ethan Ebert-Zavos
Associate, New York
Patrick Flanagan
Partner, New York
Len Jacoby
Partner, New York
Eileen Marshall
Partner, Washington, DC
Kristen Mathews
Partner, New York
Jeremy Morrison
Partner, Washington, DC
John Paul Oleksiuk
Partner, New York
Nyron J. Persaud
Partner, New York
Scott Talbot
Senior Counsel, Reston
Julia R. Brinton
Special Counsel, Washington, DC
David Hopkins
Special Counsel, Colorado
Andrew Linch
Special Counsel, London
Michael Bruno
Associate, New York
Amanda Gonzalez Burton
Associate, New York
Tony P. Guan
Associate, Santa Monica
Nathaniel Hearn Jr.
Associate, Chicago
Bomin Kim
Associate, New York
Richard Koch
Associate, Washington, DC
Allison Kutner
Associate, New York
Alexandra Leavy
Associate, New York
Amanda Pacheco
Associate, Palo Alto
Rubin Waranch
Associate, Colorado
Colleen R. Wellington-Caban
Associate, Washington, DC
Andy Zachrich
Associate, San Francisco
Patricia Myers
Paralegal Specialist, Colorado
Jill Simon
Senior Paralegal, New York
Kevin Gurley
Quantitative Analyst, New York

Related Practices & Industries

Dynavax Announces Successful Proxy Contest

June 11, 2025

Cooley advised Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, on its successful proxy contest against Deep Track Capital.

Read more

Related contacts

Bill Roegge
Partner, New York
Steve Przesmicki
Partner, San Diego
Barbara Borden
Senior Counsel, San Diego
Julia Kim
Special Counsel, New York
Patrick Reed
Associate, Palo Alto
Matthew Choy
Associate, New York
Sarah Lightdale
Partner, New York
Brian P. Golger
Associate, New York
Marina Remennik
Special Counsel, Palo Alto
Andrew Mettry
Associate
Michelle Peleg
Associate, San Francisco
Irene Sun
Associate, Palo Alto

Related Practices & Industries

View more

Admissions and credentials

New York

Rankings and accolades

The Legal 500 US: Shareholder Activism (2024 – 2025)

Law360 Mergers & Acquisitions Editorial Advisory Board (2024) 

The 'outstanding' New York-based Bill Roegge is knowledgeable on cross-border private and public M&A

Legal 500